BRADY CLARE: Open Payments
NPI 1417654773 · SAN ANGELO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 7 payments from 5 companies in 2025. Trend: 2023 $423 · 2024 $258 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $136 |
| AstraZeneca Pharmaceuticals LP | 1 | $62 |
| E.R. Squibb & Sons, L.L.C. | 3 | $62 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: CARDIOMEMS, WAINUA, CAMZYOS, ELIQUIS, Kerendia, JARDIANCE.
Industry payments across TX — which companies pay providers there.
